Cangrelor Prasugrel Transition Study

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Coronary Artery Disease
Interventions
DRUG

Cangrelor

Cangrelor IV administered as a 30 µg/kg bolus, followed by 4 µg/kg/min infusion for two hours on study Days 1 and 8

DRUG

Prasugrel

"Day 1: Subjects received prasugrel (60 mg) either during the initial cangrelor infusion (at 1.0 hours or 1.5 hours after infusion start) or within 5 minutes of discontinuing the cangrelor infusion.~Subjects will be given either 5 or 6 additional 10-mg doses to be taken every 24 hours between Day 1 and Day 8."

Trial Locations (1)

05401

Fletcher Allen Health Care, Burlington

Sponsors
All Listed Sponsors
lead

The Medicines Company

INDUSTRY